middle.news
Why Did Proteomics International’s Shares Surge? Medicare Pricing and Product Wins Explained
5:01pm on Tuesday 2nd of December, 2025 AEDT
•
Healthcare
Read Story
Why Did Proteomics International’s Shares Surge? Medicare Pricing and Product Wins Explained
5:01pm on Tuesday 2nd of December, 2025 AEDT
Key Points
US Medicare sets reimbursement price for PromarkerD at US$390.75
PromarkerD and PromarkerEso launched in Australia with initial sales recorded
New data shows OxiDx biomarker linked to improved racehorse performance
Company confirms compliance with ASX continuous disclosure rules
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE